Esketamine for the Treatment of Rett Syndrome

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

April 4, 2024

Study Completion Date

May 1, 2025

Conditions

Rett Syndrome

Interventions

DRUG

Esketamine hydrochloride

Intravenous infusion of Ketamine

Trial Locations (1)

Xiamen Children's Hospital (Children's Hospital of Fudan University at Xiamen), Xiamen

All Listed Sponsors

lead

Children's Hospital of Fudan University

OTHER